Eurofins-Cerep (XPAR:ALECR) YoY EBITDA Growth : 6.01% (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Eurofins-Cerep YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Eurofins-Cerep's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 6.01%.

Eurofins-Cerep's EBITDA per Share for the six months ended in Dec. 2024 was €1,050.60.

Eurofins-Cerep YoY EBITDA Growth Historical Data

The historical data trend for Eurofins-Cerep's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins-Cerep YoY EBITDA Growth Chart

Eurofins-Cerep Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

20.30

72.22

19.28

-29.66

-2.34

Eurofins-Cerep Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															15.16	-35.52	-24.41	-12.33	6.01

Eurofins-Cerep YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Eurofins-Cerep's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(1777.6	-	1820.2)	/	\| 1820.2 \|
=	-2.34 %

Eurofins-Cerep's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(1050.6	-	991)	/	\| 991 \|
=	6.01 %

Eurofins-Cerep YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Eurofins-Cerep's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Eurofins-Cerep Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins-Cerep SA (XPAR:ALECR) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Le bois l Eveque, Celle l Evescault, FRA, 86600

Website

http://www.cerep.fr

Eurofins-Cerep SA provides in vitro pharmacology, in vitro ADME-Tox and in vivo PK services and solutions. The company also offers cost-effective drug discovery by identifying at early stages drug candidates and eliminating them. Some solutions provided by the company are - compound management, high-throughout screening, in vitro safety profiling, lead optimization profiling, in vitro ADME profiling, and in vivo PK.

Eurofins-Cerep Headlines

No Headlines